The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
| Title |
Addition of intravenous aminophylline to inhaled beta<sub>2</sub>‐agonists in adults with acute asthma
|
|---|---|
| Published in |
Cochrane database of systematic reviews, December 2012
|
| DOI | 10.1002/14651858.cd002742.pub2 |
| Pubmed ID | |
| Authors |
Parameswaran Nair, Stephen J Milan, Brian H Rowe |
| Abstract |
Asthma is a chronic condition in which sufferers may have occasional or frequent exacerbations resulting in visits to the emergency department (ED). Aminophylline has been used extensively to treat exacerbations in acute asthma settings; however, it's role is unclear especially with respect to any additional benefit when added to inhaled beta(2)-agonists. |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 14% |
| United States | 1 | 14% |
| Kenya | 1 | 14% |
| Japan | 1 | 14% |
| Egypt | 1 | 14% |
| Unknown | 2 | 29% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 7 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 226 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Korea, Republic of | 1 | <1% |
| Chile | 1 | <1% |
| Colombia | 1 | <1% |
| Unknown | 223 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 28 | 12% |
| Researcher | 26 | 12% |
| Student > Bachelor | 19 | 8% |
| Student > Ph. D. Student | 13 | 6% |
| Other | 13 | 6% |
| Other | 43 | 19% |
| Unknown | 84 | 37% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 87 | 38% |
| Nursing and Health Professions | 15 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 4% |
| Agricultural and Biological Sciences | 6 | 3% |
| Psychology | 4 | 2% |
| Other | 13 | 6% |
| Unknown | 92 | 41% |
Attention Score in Context
This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 December 2023.
All research outputs
#3,978,068
of 26,414,132 outputs
Outputs from Cochrane database of systematic reviews
#6,519
of 13,224 outputs
Outputs of similar age
#36,866
of 292,083 outputs
Outputs of similar age from Cochrane database of systematic reviews
#84
of 196 outputs
Altmetric has tracked 26,414,132 research outputs across all sources so far. Compared to these this one has done well and is in the 84th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,224 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 33.7. This one has gotten more attention than average, scoring higher than 50% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 292,083 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 196 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 57% of its contemporaries.